Skip to content
value.today

Orgenesis Inc.

ORGS
$15 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$8 M
annual
value.today research
Net income
$6 M
81.6% margin
value.today research
Employees
—

Orgenesis Inc. in brief

Orgenesis Inc. is a listed company in the Biotechnology industry, based in the USA. Its last known market value was $15 M (January 2024); there is no current figure. In its latest reported year it had sales of $8 M and a net profit of $6 M, about 82 cents of profit for every dollar of sales. Its shares trade under the symbol ORGS (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$29 M$59 M$88 M$118 M20202021202220232024

World rank over time

▼ down 9,880 places since 2020
2020-01-01: #20109#20,10920202021-01-01: #17844#17,84420212022-01-07: #25465#25,46520222022-12-25: #26105#26,10520222023-07-30: #27653#27,65320232024-01-05: #29989#29,9892024

Rank in USA: #3,888 (Jan 2020) · #3,637 (Jan 2021) · #4,763 (Jan 2022) · #4,924 (Dec 2022) · #5,009 (Jul 2023) · #4,432 (Jan 2024)

Annual results

Revenue
$8 M
Operating income
—
Net income
$6 M

Markets and events: Orgenesis Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
5,258
1.24 days to cover
Shares sold short, last 24 reportsAll stocks →

Fails to deliver

  • : 100 shares at $1.00
  • : 759 shares at $1.33
  • : 821 shares at $1.53
  • : 761 shares at $1.53
  • : 8 shares at $2.27

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

How Orgenesis Inc. compares in Biotechnology

  • Revenue$8 M · higher than 39% of 647
  • Net margin81.6% · higher than 99% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Orgenesis Inc.🇺🇸$15 M—81.6%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Orgenesis Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Orgenesis Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Orgenesis Inc.? Suggest a correction